Skip to main content
. 2022 Jan;28(1):10.18553/jmcp.2022.28.1.119. doi: 10.18553/jmcp.2022.28.1.119

TABLE 3.

Votes on Contextual Considerations and Potential Other Benefits or Disadvantages for Any Effective Treatment for Myasthenia Gravis

When making judgments of overall long-term value for money, what is the relative priority that should be given to any effective treatment for gMG, on the basis of the following contextual considerations?
Contextual consideration Very low priority Low priority Average priority High priority Very high priority
Acuity of need for treatment of individual patients based on the severity of the condition being treated 0 2 2 7 0
Magnitude of the lifetime impact on individual patients of the condition being treated 0 0 1 7 3

gMG = generalized myasthenia gravis.